Study protocol for a 10-year prospective observational study, examining lymphoedema and patient-reported outcome after breast reconstruction

Introduction Over the last decades, treatment of breast cancer has become increasingly more effective. Consequently, an increasing number of women are living with late effects of breast cancer treatment, including disfiguring scars, deformity or asymmetry of the breast, secondary lymphoedema and oth...

Full description

Saved in:
Bibliographic Details
Main Authors: Cecilie Mullerup Laustsen-Kiel, Elisabeth Lauritzen, Linnea Langhans, Tine Engberg Damsgaard
Format: Article
Language:English
Published: BMJ Publishing Group 2021-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/12/e052676.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850126728584757248
author Cecilie Mullerup Laustsen-Kiel
Elisabeth Lauritzen
Linnea Langhans
Tine Engberg Damsgaard
author_facet Cecilie Mullerup Laustsen-Kiel
Elisabeth Lauritzen
Linnea Langhans
Tine Engberg Damsgaard
author_sort Cecilie Mullerup Laustsen-Kiel
collection DOAJ
description Introduction Over the last decades, treatment of breast cancer has become increasingly more effective. Consequently, an increasing number of women are living with late effects of breast cancer treatment, including disfiguring scars, deformity or asymmetry of the breast, secondary lymphoedema and other physical and psychosocial late effects. Data from this study will provide knowledge on how to guide breast reconstruction in the future towards outcomes with fewer complications, higher long-term quality of life (QoL) and satisfaction with the aesthetic outcome. The development of secondary lymphoedema, for which the effect of breast reconstruction has yet to be established, will be thoroughly examined.Methods and analysis Women receiving breast reconstruction (autologous and implant based) at the Department of Plastic Surgery and Burns Treatment, Rigshospitalet, will be invited to participate. The patients will be followed for 10 years postoperatively. Demographic, health-related, oncological characteristics and treatment data will be registered. Validated assessment tools, such as the BREAST-Q and Beck Depression Inventory, will be used to measure an extensive range of clinical outcomes, including QoL, life and aesthetic satisfaction and depression. Arm range of motion will be measured with a goniometer and lymphoedema by bioimpedance spectroscopy, compared with circular arm measurements.Ethics and dissemination This study will be conducted according to the 5th version of the Helsinki Declaration. The regional ethical committee for Capital Region Denmark did not find the study notifiable, according to the law of the committee § 1, part 4. All data will be anonymised before its publication. This study will be conducted according to the Danish data protection regulation and is catalogued and approved by the Capital Region Head of Knowledge Centre. According to the Danish health law § 46, part 2, this study does not need the Danish Patient Safety Authority’s approval. The findings of this study will be submitted to international peer-reviewed journals.
format Article
id doaj-art-ece54549400547dd8c8eb672fd7f209a
institution OA Journals
issn 2044-6055
language English
publishDate 2021-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-ece54549400547dd8c8eb672fd7f209a2025-08-20T02:33:51ZengBMJ Publishing GroupBMJ Open2044-60552021-12-01111210.1136/bmjopen-2021-052676Study protocol for a 10-year prospective observational study, examining lymphoedema and patient-reported outcome after breast reconstructionCecilie Mullerup Laustsen-Kiel0Elisabeth Lauritzen1Linnea Langhans2Tine Engberg Damsgaard3Department of Plastic Surgery and Burns Treatment, Rigshospitalet, Copenhagen, DenmarkDepartment of Plastic Surgery and Burns Treatment, Rigshospitalet, Copenhagen, DenmarkDepartment of Plastic Surgery and Burns Treatment, Rigshospitalet, Copenhagen, DenmarkDepartment of Plastic Surgery and Burns Treatment, Rigshospitalet, Copenhagen, DenmarkIntroduction Over the last decades, treatment of breast cancer has become increasingly more effective. Consequently, an increasing number of women are living with late effects of breast cancer treatment, including disfiguring scars, deformity or asymmetry of the breast, secondary lymphoedema and other physical and psychosocial late effects. Data from this study will provide knowledge on how to guide breast reconstruction in the future towards outcomes with fewer complications, higher long-term quality of life (QoL) and satisfaction with the aesthetic outcome. The development of secondary lymphoedema, for which the effect of breast reconstruction has yet to be established, will be thoroughly examined.Methods and analysis Women receiving breast reconstruction (autologous and implant based) at the Department of Plastic Surgery and Burns Treatment, Rigshospitalet, will be invited to participate. The patients will be followed for 10 years postoperatively. Demographic, health-related, oncological characteristics and treatment data will be registered. Validated assessment tools, such as the BREAST-Q and Beck Depression Inventory, will be used to measure an extensive range of clinical outcomes, including QoL, life and aesthetic satisfaction and depression. Arm range of motion will be measured with a goniometer and lymphoedema by bioimpedance spectroscopy, compared with circular arm measurements.Ethics and dissemination This study will be conducted according to the 5th version of the Helsinki Declaration. The regional ethical committee for Capital Region Denmark did not find the study notifiable, according to the law of the committee § 1, part 4. All data will be anonymised before its publication. This study will be conducted according to the Danish data protection regulation and is catalogued and approved by the Capital Region Head of Knowledge Centre. According to the Danish health law § 46, part 2, this study does not need the Danish Patient Safety Authority’s approval. The findings of this study will be submitted to international peer-reviewed journals.https://bmjopen.bmj.com/content/11/12/e052676.full
spellingShingle Cecilie Mullerup Laustsen-Kiel
Elisabeth Lauritzen
Linnea Langhans
Tine Engberg Damsgaard
Study protocol for a 10-year prospective observational study, examining lymphoedema and patient-reported outcome after breast reconstruction
BMJ Open
title Study protocol for a 10-year prospective observational study, examining lymphoedema and patient-reported outcome after breast reconstruction
title_full Study protocol for a 10-year prospective observational study, examining lymphoedema and patient-reported outcome after breast reconstruction
title_fullStr Study protocol for a 10-year prospective observational study, examining lymphoedema and patient-reported outcome after breast reconstruction
title_full_unstemmed Study protocol for a 10-year prospective observational study, examining lymphoedema and patient-reported outcome after breast reconstruction
title_short Study protocol for a 10-year prospective observational study, examining lymphoedema and patient-reported outcome after breast reconstruction
title_sort study protocol for a 10 year prospective observational study examining lymphoedema and patient reported outcome after breast reconstruction
url https://bmjopen.bmj.com/content/11/12/e052676.full
work_keys_str_mv AT ceciliemulleruplaustsenkiel studyprotocolfora10yearprospectiveobservationalstudyexamininglymphoedemaandpatientreportedoutcomeafterbreastreconstruction
AT elisabethlauritzen studyprotocolfora10yearprospectiveobservationalstudyexamininglymphoedemaandpatientreportedoutcomeafterbreastreconstruction
AT linnealanghans studyprotocolfora10yearprospectiveobservationalstudyexamininglymphoedemaandpatientreportedoutcomeafterbreastreconstruction
AT tineengbergdamsgaard studyprotocolfora10yearprospectiveobservationalstudyexamininglymphoedemaandpatientreportedoutcomeafterbreastreconstruction